🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Sharing our review discussing the role of consolidative TRT in ES-SCLC in the era of immunotherapy. We need to find the appropriate population, dose and timing of TRT. doi.org/10.1177/175883…

ARREST-2 opened for accrual yesterday! This is a new randomized phase 2/3 trial for patients with >10 mets that hopes to challenge the current radiotherapy paradigm for patients with polymetastatic disease. Thanks to the whole team esp @drdavidpalma and Glenn Bauman, MD London Health Sciences Centre

Exciting RCT presented at #ASTRO2023 by Melissa O'Neil MRT(T) on use of diagnostic CT in lieu of CT sim for palliative patients, improving workflow and saving time/resources 👏👏 Great work!! David Palma, MD, PhD Tim Nguyen Chris Goodman @Drjoannalaba

#ASTRO2023 in the books. So inspiring seeing innovative #radonc research, exchanging ideas and meeting colleagues from around the world. Hope to see everyone in DC next year!

Just out in The Lancet - our clinical picture showing a patient with two lung metastases (from #colorectalcancer) and a large incidental hiatal hernia. How would you have treated? David Palma, MD, PhD doi.org/10.1016/S0140-…

Check out our clinical trial protocol for SABR DETECT, now in publication #liquidbiopsy #lungcancer #sabr

Now online IJROBP - The Red Journal Early results of the randomized Hope trial. Is ultra-HypoRT to the pelvis post prostate BT as well tolerated as conventional RT? sciencedirect.com/science/articl… Alfonso Gomez-Iturriaga Dr Kevin Martell Dr Stanley Liu

📢 STORM trial breaking results at #ESTRO25! 🧪 MDT vs ENRT+MDT for nodal oligorecurrent PCa. 🧬 ENRT+MDT: ✅ Superior bRFS (57% vs 41%, p=0.014) ✅ Superior pelvic control (lrRFS 85% vs 62%, p=0.006) ✅ Superior MFS (76% vs 63%, p=0.06) ❌ No increase in ≥G2 GU/GI toxicity

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

Come on #ASCO25, this 💯 should have been a plenary! 7% improvement in 8-yr OS w exercise in adjuvant colon ca, greater than benefit for adding oxali to 5-FU (5% at 10 yrs in MOSAIC). Exercise = $ effective, ~0 tox, & gives pts sense of empowerment. Congrats Chris Booth et al!